LobbyingRapid Therapeutic Science Laboratories lobbying by quarter
Rapid Therapeutic Science Laboratories's latest lobbying report covers Q2 2023, at $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Rapid Therapeutic Science Laboratories
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Jeffrey J. Kimbell & Associates | $30K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN HERZOG | Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President | Q4 2022 |
| JOHN R RAY | Legislative Assistant, Rep. Mike Kelly | Q4 2022 |
| KEITH STUDDARD | Legislative Director, Rep. Marsha Blackburn | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/07/20for Q2 2023 | Jeffrey J. Kimbell & Associates | $10K |
| 23/05/01for Q1 2023 | Jeffrey J. Kimbell & Associates | $10K |
| 23/01/18for Q4 2022 | Jeffrey J. Kimbell & Associates | $10K |